Mice Model Market by Type, Technology, Therapeutic Area, Application

List of Tables

The Mice Model Market was valued at USD 1.49 billion in 2023, expected to reach USD 1.61 billion in 2024, and is projected to grow at a CAGR of 8.34%, to USD 2.61 billion by 2030.

The mice model market encompasses the use of genetically engineered mice in biomedical research, offering a profound scope as an essential tool for understanding human diseases, drug development, and therapeutic testing. These models are pivotal due to their genetic similarities with humans, facilitating insights into cancer, cardiovascular diseases, metabolic disorders, and more. The necessity of mice models is underscored by their ability to model human disease phenotypes, thus becoming invaluable in translational and preclinical research. Application-wise, they are employed across pharmaceuticals, biotechnology, and academic research institutions, with end-user scope spanning drug discovery, toxicology, and genetic research. Growth in this market is driven by increased government funding for genomic research, rising demand for personalized medicine, and advancements in CRISPR and other genetic engineering technologies. The surge in chronic disease prevalence also bolsters the need for efficient animal models. However, ethical concerns regarding animal testing, along with stringent regulatory frameworks, present significant challenges. Additionally, the complexity involved in developing genetically engineered models and the high cost of maintenance can hinder market expansion. Opportunities lie in developing more sophisticated humanized mice models and enhancing imaging and surveillance technologies to gather more precise data. Embracing open-access platforms for data sharing could foster broader collaborative research and accelerate advancements. Innovations in non-invasive imaging techniques and digital pathology are potent areas for research and development. The nature of the mice model market is highly dynamic and competitive, with continuous emphasis on innovations that enhance model accuracy and reduce ethical concerns. For businesses, tapping into emerging trends like AI-driven data analysis and expanding into untapped regions with growing clinical research infrastructure may yield substantial growth. Overall, while the market faces challenges, the continual demand for efficient research models offers robust growth potential.

KEY MARKET STATISTICS
Base Year [2023]	USD 1.49 billion
Estimated Year [2024]	USD 1.61 billion
Forecast Year [2030]	USD 2.61 billion
CAGR (%)	8.34%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mice Model Market

The Mice Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Escalating use of mice models for drug testing and research of immune disease
- Rising investments and grants coupled with surging pharmaceutical R&D activities
Market Restraints
- High costs associated with development of mice models
Market Opportunities
- Emerging implementation of AI and ML in mice modeling
- Advent of CRISPR-Cas9 technology in mice modeling
Market Challenges
- Stringent regulations and laws considering the ethical use of animals in research

Porter's Five Forces: A Strategic Tool for Navigating the Mice Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mice Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mice Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mice Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mice Model Market

A detailed market share analysis in the Mice Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mice Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mice Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mice Model Market

A strategic analysis of the Mice Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mice Model Market, highlighting leading vendors and their innovative profiles. These include Applied StemCell, Inc., Aragen Life Sciences Ltd., Biocytogen Boston Corporation, Charles River Laboratories International, Inc., CompareNetworks, Inc., Creative Biolabs., Crown Bioscience by JSR Life Sciences, LLC, Cyagen US Inc. by PolyGene AG, Envigo by Inotiv, Inc., GenOway, Harbour BioMed, Horizon Discovery Ltd. by PerkinElmer, Inc., inGenious Targeting Laboratory, Inc., ITR Laboratories Canada, Janvier Labs, Marshall BioResources, MD Biosciences, Mirimus, Inc., Oncodesign, SA, Ozgene Pty Ltd., PhoenixBio Co., Ltd., Shanghai Model Organisms Center, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, TransCure bioServices, Translational Drug Development, LLC, Transnetyx, Inc., Urosphere SAS, Vivo Bio Tech Ltd., and XenOPAT SL by Bellvitge Biomedical Research Institute.

Market Segmentation & Coverage

This research report categorizes the Mice Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Type, market is studied across Conditioned/Surgically Modified Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Inbred Mice, and Outbred Mice.
Based on Technology, market is studied across CRISPR/CAS9, Embryonic Stem Cell Injection, Microinjection, and Nuclear Transfer.
Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Immunology, Metabolic Diseases, Neurology, and Oncology.
Based on Application, market is studied across Drug Discovery & Development, Personalized Medicine, and Research Application.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-4316E4E89369

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Escalating use of mice models for drug testing and research of immune disease
  - 5.1.1.2. Rising investments and grants coupled with surging pharmaceutical R&D activities
- 5.1.2. Restraints
  - 5.1.2.1. High costs associated with development of mice models
- 5.1.3. Opportunities
  - 5.1.3.1. Emerging implementation of AI and ML in mice modeling
  - 5.1.3.2. Advent of CRISPR-Cas9 technology in mice modeling
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulations and laws considering the ethical use of animals in research
5.2. Market Segmentation Analysis
- 5.2.1. Type: Growing significance of genetically engineered mice for evaluating gene therapy outcomes
- 5.2.2. Application: Rising adoption of mice models to explore therapeutic efficacy and safety profiles before clinical trials
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Mice Model Market, by Type

6.1. Introduction
6.2. Conditioned/Surgically Modified Mice
6.3. Genetically Engineered Mice
6.4. Hybrid/Congenic Mice
6.5. Inbred Mice
6.6. Outbred Mice

7. Mice Model Market, by Technology

7.1. Introduction
7.2. CRISPR/CAS9
7.3. Embryonic Stem Cell Injection
7.4. Microinjection
7.5. Nuclear Transfer

8. Mice Model Market, by Therapeutic Area

8.1. Introduction
8.2. Cardiovascular Diseases
8.3. Immunology
8.4. Metabolic Diseases
8.5. Neurology
8.6. Oncology

9. Mice Model Market, by Application

9.1. Introduction
9.2. Drug Discovery & Development
9.3. Personalized Medicine
9.4. Research Application

10. Americas Mice Model Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Mice Model Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Mice Model Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Biocytogen Officially Launches RenMice Series
- 13.3.2. Introducing NeoMab: GemPharmatech's Innovative Antibody Gene Humanized Mouse Model
- 13.3.3. A Mouse That Roars: Chinese Scientists Create The First Mammal With Fully Reprogrammed Genes
- 13.3.4. UCLA Researchers Develop First Human Genomic Transgenic Mouse Model Of Huntington's Disease
13.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Applied StemCell, Inc.
2. Aragen Life Sciences Ltd.
3. Biocytogen Boston Corporation
4. Charles River Laboratories International, Inc.
5. CompareNetworks, Inc.
6. Creative Biolabs.
7. Crown Bioscience by JSR Life Sciences, LLC
8. Cyagen US Inc. by PolyGene AG
9. Envigo by Inotiv, Inc.
10. GenOway
11. Harbour BioMed
12. Horizon Discovery Ltd. by PerkinElmer, Inc.
13. inGenious Targeting Laboratory, Inc.
14. ITR Laboratories Canada
15. Janvier Labs
16. Marshall BioResources
17. MD Biosciences
18. Mirimus, Inc.
19. Oncodesign, SA
20. Ozgene Pty Ltd.
21. PhoenixBio Co., Ltd.
22. Shanghai Model Organisms Center, Inc.
23. Taconic Biosciences, Inc.
24. The Jackson Laboratory
25. TransCure bioServices
26. Translational Drug Development, LLC
27. Transnetyx, Inc.
28. Urosphere SAS
29. Vivo Bio Tech Ltd.
30. XenOPAT SL by Bellvitge Biomedical Research Institute